Cytadren
FDA Approves Kadcyla for Late-stage Breast Cancer »
"The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.
HER2 is a protein involved in normal cell growth. It is foun"...
Read the FDA Approves Kadcyla for Late-stage Breast Cancer article »
Cytadren
Cytadren Patient Information Including Side Effects
Brand Names: Cytadren
Generic Name: aminoglutethimide (Pronunciation: ah mee no glue TEH tha mide)
- What is aminoglutethimide (Cytadren)?
- What are the possible side effects of aminoglutethimide (Cytadren)?
- What is the most important information I should know about aminoglutethimide (Cytadren)?
- What should I discuss with my healthcare provider before taking aminoglutethimide (Cytadren)?
- How should I use aminoglutethimide (Cytadren)?
- What happens if I miss a dose (Cytadren)?
- What happens if I overdose (Cytadren)?
- What should I avoid while using aminoglutethimide (Cytadren)?
- What other drugs will affect aminoglutethimide (Cytadren)?
- Where can I get more information?
What is aminoglutethimide (Cytadren)?
Aminoglutethimide is an anti-hormone medication. Aminoglutethimide interferes with the body's production of certain hormones.
Aminoglutethimide is used in the treatment of conditions which cause the body to make too much of certain hormones (Cushing's syndrome).
Aminoglutethimide may also be used for purposes other than those listed in this medication guide.
What are the possible side effects of aminoglutethimide (Cytadren)?
If you experience any of the following serious side effects from aminoglutethimide, contact your doctor immediately:
- an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); or
- fainting or dizziness, especially when standing up.
Other, less serious side effects may be more likely to occur. Continue taking aminoglutethimide and talk to your doctor if you experience:
- dizziness, drowsiness, poor coordination, or weakness;
- nausea, vomiting, or loss of appetite;
- headache; or
- rash and itching.
Other side effects have also been reported. Discuss with your doctor any side effect that occurs during treatment with aminoglutethimide.
Read the Cytadren (aminoglutethimide) Side Effects Center for a complete guide to possible side effects »
What is the most important information I should know about aminoglutethimide (Cytadren)?
Aminoglutethimide should only be administered under the supervision of a qualified healthcare provider experienced with its use and hazards. Treatment should usually begin in a hospital.
Use caution when driving, operating machinery, or performing other hazardous activities. Aminoglutethimide may cause drowsiness and dizziness. If you experience drowsiness or dizziness, avoid these activities.
Use alcohol cautiously. Alcohol may increase the effects of aminoglutethimide.
Aminoglutethimide may stop your body from responding to conditions of stress, such as surgery, injury, or sudden illness. Talk to your doctor about the possible side effects from treatment with aminoglutethimide.
Additional Cytadren Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Breast Cancer
Find support and advances in treatment.






